RxSight (RXST) Receivables (2020 - 2026)

RxSight (RXST) has 7 years of Receivables data on file, last reported at $22.4 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 27.51% year-over-year to $22.4 million; the trailing twelve-month figure through Mar 2026 stood at $22.4 million (down 27.51% YoY), and the FY2025 full-year result was $23.4 million, down 22.19% from the prior year.
• Receivables for Q1 2026 stood at $22.4 million, down from $23.4 million in the prior quarter.
• Across five years, Receivables topped out at $31.0 million in Q1 2025 and bottomed at $5.6 million in Q1 2022.
• The 5-year median for Receivables is $21.6 million (2024), against an average of $19.2 million.
• The widest annual swing landed in 2022, when Receivables soared 125.34%; it then dropped 27.51% in 2026.
• A 5-year view of Receivables shows it stood at $11.0 million in 2022, then soared by 85.11% to $20.3 million in 2023, then soared by 48.17% to $30.0 million in 2024, then decreased by 22.19% to $23.4 million in 2025, then decreased by 4.02% to $22.4 million in 2026.
• The last three Receivables figures came in at $22.4 million (Q1 2026), $23.4 million (Q4 2025), and $24.2 million (Q3 2025), per Business Quant data.

Peer Comparison